GlaucoT Teknoloji A.Ş. is pleased to be selected to attend the Ophthalmology Innovation Summit XIV on November 22nd in San Diego. At this prestigious event, we will introduce our wearable neuroprotective glaucoma treatment device and mobile camera-based intraocular pressure (IOP) measurement system to global ophthalmology industry leaders and investors. 

GlaucoT treatment patent granted in US.

WE ARE IN IT!

JAN 5-8, 2023

LAS VEGAS, NV & DIGITAL

 We are attending to Eureka Park™ at CES 2023. Eureka Park™ at CES® is where new ideas are funded. It’s the buzzworthy startup arena that provides a unique opportunity to launch a new product, service or idea. We are looking forward to meeting with the potential customers and investers at Eureka Park.

We are really excited to be selected for the EIT Health 2022 Catapult Program. The programme recognises and awards the very best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.

 It is our pleasure to announce that our start-up “GlaucoT” has been selected among 16 companies to present at the Start-Up Stadium event from hundreds of startups and entrepreneurs from around the world. We will have the opportunity to introduce Glaucot and our innovation “Wearable Glaucoma Treatment Device” to key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital. 

GlaucoT has been selected among 5 startup to participate in the  Bio Convention in the USA.

BIOStartup Demo Day supported by Association of Research-Based Pharmaceutical Companies in Turkey AiFD.

 GlaucoT won first place out of 471 projects participating in TET R&D Project Brokerage Event organized by TET - Electrical and Electronics Exporters Association.

 GlaucoT, World First, noninvasive Glacuoma treatment device on the way, pleasure to get support from TTGV HIT.

Our Co-founder Abdulkadir Oduncu. MD has attended immense training at Acıbadem Incubation center for GlaucoT project commercialization.